AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Positron Emission Tomography
Description: Undergo PET scan
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET scan
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thioguanine
Description: Given PO
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thioguanine
Description: Given PO
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vincristine
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine
Description: Given IV
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: X-Ray Imaging
Description: Undergo X-ray
Study NCT06210750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo X-ray
Study NCT05105464 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYHA1815
Description: Subjects will receive SYHA1815 orally.
Study NCT05337787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: flipped classroom approach
Description: The students in the experimental group were trained using the flipped learning model.
Study NCT06504537 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: THERAGUN PERCUSSION THERAPY
Description: In Group A, Patients will receive Theragun Percussion therapy along with routine Physical Therapy Treatment. The range of motion of lateral flexion and forward flexion will take by using a bubble inclinometer. Then the patient will place in a sitting position with the shoulder area exposed. Percussion therapy by using the Theragun device will give by a specific order. Treatment will start with the percussion head applied at the origin and insertion heads of the trapezius, Rhomboid and scalene muscle for 3-4 minutes each. Following this the percussive Theragun applicator will applied with circular strokes along the length of the muscle for 3 minutes. The pressure of application will adjust to the subject's tolerance.
Study NCT06504537 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COMPRESSION THERAPY
Description: In Group B, Compression therapy will be administered to the patients by migraine relief gel cap for 25 minutes during migraine attacks. The cap will store in a freezer (15-18°C). At the onset of the migraine attacks, patients wore the cap and used it. We will choose 25 minutes as the time for application of the gel cap based on the results of two published studies.(23) Headache severity will measured by Visual Analogue Scale and pain relief will measured on a similar scale. Analgesic treatment will not take within 25 minutes after the onset of cold therapy. If patients did not experience adequate relief from the headache, we will allow them to use analgesics 25 minutes after the onset of cold therapy. The routine physical treatment will be same as in group A.
Study NCT04996173 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Spray cryotherapy
Description: A novel FDA cleared technique that allows for Liquid nitrogen (LN2) to be delivered in a metered fashion via a catheter through a flexible bronchoscope.
Study NCT04996173 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Ballon Dilation
Description: An endoscopic balloon that is inflated with water to pressures between 45 and 131 psi (3 to 9 atm) using a syringe and pressure manometer.
Study NCT04996173 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ballon Dilation
Description: An endoscopic balloon that is inflated with water to pressures between 45 and 131 psi (3 to 9 atm) using a syringe and pressure manometer.
Study NCT04996173 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Radial Incision
Description: Carbon dioxide (CO2) laser or Monopolar electrocautery knife
Study NCT04996173 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Radial Incision
Description: Carbon dioxide (CO2) laser or Monopolar electrocautery knife
Study NCT05126186 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: haplo-SCT with PTCy
Description: Conditioning regimen Fludarabine (30mg/m2/day from day -6 to day -4), Cyclophosphamide (14.5 mg/kg/day at day -6 and day -5) except for patients who received a total dose of Cyclophosphamide >100mg/Kg during the first Bone Marrow Transplantation Total Body Irradiation (2 Gray on day -1).~Source of stem cell source Peripheral blood stem cell Minimal target dose of 4.106 CD34+ cells/kg of recipient~GvHD prophylaxis Cyclophosphamide 50 mg/Kg/day at D+3 and D+4 Ciclosporine from day+5 (residual 200 à 300ng/l) Mycophenolate mofetyl at 15mg/Kg x2/day from day+5~Prevention of EBV reactivation Rituximab : 150mg/m2 intravenously at Day+5 post Haplo-SCT Each infusion of Rituximab will be preceded by administration of anti-pyretic and an antihistaminic.
Study NCT06002399 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: cataract surgery
Description: cataract surgery
Study NCT06002399 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cataract surgery
Description: cataract surgery
Study NCT05092542 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Refugee and Immigrant Well-being Project (RIWP)
Description: 6-month mental health intervention that pairs university students with newcomers to engage in mutual learning, resource mobilization, and social change efforts
Study NCT04858750 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Placement of ureteral D-J stent after ureteroscopic holmium laser lithotripsy
Description: During ureteral holmium laser lithotripsy operation, after the stones were fragmented, the D-J stents of three different types were placed, the insertion process are exactly the same.
Study NCT05903729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental therapy treatment
Description: The group will receive NDT therapy
Study NCT05903729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physiotherapy
Description: conventional physiotherapy
Study NCT05046847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3811
Description: TQB3811 is a second-generation TrkA inhibitor.
Study NCT05970874 — intervention group
Intervention type: DEVICE
Intervention: Hand grip strength measureme
Description: Hand grip strength (HSG) was measured in kg with the CAMRY Digital Hand Dynamometer (Model No. EH101, CAMRY).
Study NCT05357443 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Gastric bypass with transection of vagal nerves
Description: Vagal nerve interruption above the level of the stomach is a known treatment for complicated peptic ulcer disease. It is not commonly performed during routine gastric bypass. The vagi are, however, interrupted part-way down the stomach to create the gastric pouch. This is the pars flaccida technique.
Study NCT05357443 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Gastric bypass without transection of vagal nerves
Description: Dissection between the neurovascular bundle and the stomach, spareing the vagus nerves. This is the perigastric technique.
Study NCT05656768 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Constant Routine Protocol
Description: A constant routine protocol is used to directly examine markers of circadian rhythmicity (e.g., melatonin and core body temperature). A constant routine protocol requires an individual to remain in a dimly lit room, in a constant semi-recumbent posture, and remain awake for more than 24 hours. It is one of two gold-standard research protocols for examining circadian rhythms in humans.
Study NCT05691998 — intervention group
Intervention type: OTHER
Intervention: Prosthetic foot questionnaire
Description: Prosthetic foot related questions will be asked to the patients
Study NCT00992940 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Patient-Controlled Sedation/Analgesia
Description: Patient controls delivery of sedation and analgesia requirements.
Study NCT00992940 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anesthetist-Controlled Sedation/Analgesia
Description: All sedation and analgesia requirements are determined and delivered by the attending anesthetist.
Study NCT06443164 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Empowered Relief
Description: Pain Management Course that has been used to treat pain in patients with different pain conditions.
Study NCT06443164 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Gender Affirming surgery without any attention to pain conditions prior to surgery.
Study NCT05554484 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood-derived tolerogenic dendritic cells
Description: AMI-DC, autologous dendritic cell product Inject 7.5 x 106 cells hypodermically to 1\~4 sites in the left axillary lymph node between 5-7 days after PCI and 12-14 days after PCI. . The administration must be done within 30 minutes after fully liquified.
Study NCT05114395 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Telerehabilitation Program
Description: See experimental and active comparator arms.
Study NCT05114395 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic Floor Face-to-Face Program
Description: See experimental and active comparator arms.
Study NCT06311045 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Description: Participants will take two NAC 600mg capsules daily for four weeks.
Study NCT06311045 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will take two placebo 600mg capsules daily for four weeks.
Study NCT06311045 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positive Airway Pressure (PAP) Therapy
Description: All participants will receive PAP therapy per standard of care for OSA.
Study NCT05362422 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: long-term paired associative stimulation
Description: Paired associative stimulation (PAS) administered 3-5 times per week for 4 weeks to upper limbs. PAS comprises transcranial magnetic stimulation (eXimia magnetic stimulator, Nexstim Ltd, Helsinki, Finland) and peripheral nerve stimulation (given with Dantec Keypoint® electroneuromyography device (Natus Medical Incorporated, Pleasanton, CA, USA)).
Study NCT05362422 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham long-term paired associative stimulation
Description: Sham transcranial magnetic stimulation and sham peripheral nerve stimulation.
Study NCT06354582 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin C Injection
Description: Drug Specification: 5ml: 1g. Method: parturients in each group will be intravenously injected with corresponding dose after receiving epidural labor analgesia.
Study NCT06354582 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: The placebo comparator will receive normal saline with the same volume and be administered after the induction of epidural labor anesthesia.
Study NCT05414981 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ABI-H3733
Description: 25 mg or 100 mg tablets for oral administration
Study NCT05414981 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 25 mg or 100 mg tablets for oral administration
Study NCT04781621 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robotic Gait Training
Description: Participants will wear an exoskeleton suit and receive robotic gait training with a physical therapist for 90 minutes each week. Robot gait training will include standing and walking activities while wearing a robot suit. Participants will be asked to completed questionnaires about walking and function. They will also be asked to wear a watch measuring their heart rate monitor.
Study NCT04781621 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care Gait Training
Description: Participants receive usual care gait training with a physical therapist for 90 minutes each week. Usual care gait training may include standing and walking activities while using a treadmill or walker. Participants will be asked to completed questionnaires about walking and function. They will also be asked to wear a watch measuring their heart rate monitor and number of steps.
Study NCT05080972 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: in-the-kNOW mobile app
Description: in-the-kNOW is a mobile app with restricted access through a single-use registration code.~The app will be developed with regular input from Black women enrolled in Atlanta Healthy Start Initiative (AHSI).~The app will have culturally- and contextually targeted HIV prevention and optimal sexual health messaging.~Each participant will have 4 months to engage with the app, with e-reminders in time intervals preferred by the participants (a minimum of 3 times per week) via push notifications. During the 4-month study period, participants will receive push notifications to encourage the use of all app domains: My Logger, My Test, My Resources, and My Circle.~Research staff will complete 2-month check-ins via phone call or video chat with participants.
Study NCT05080972 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The control condition will be a one-time virtual women's health counseling session with a healthcare provider. Participants will get information on~1. Sexual Transmitted Infections (STI)/HIV prevention,~2. Family planning, and~3. General health promotion (e.g., exercise and diet).~The control condition provides access to HIV prevention materials that are publicly available but that do not offer the dynamic and individually customized features of the health communication/new media research approach proposed herein.~Control group participants will continue to receive the usual care associated with Atlanta Healthy Start Initiative (AHSI) enrollment.~The control group will not have access to intervention content (e.g. commodity ordering) until after the study has concluded.~Research staff will complete 2-month check-ins via phone call or video chat with participants.
Study NCT05376358 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MoodRing App
Description: Adolescents and parents in the MR arm will receive instructions to download the MR app and AWARE app, customize the app, utilize an app-based self-guided onboarding, and review questions with the research team. The MR app provides the adolescent and their parent a notification to view a weekly report predicting their mood score (i.e. depression severity level similar to the Patient health questionnaire-9). The MR app will provide a library of coping strategies for adolescents and opportunities to self-track their mood.~Clinicians in the MR Arm will get access to a MR portal online. They will be able to view patients they are a provider for. The clinician will receive in-person and/or video-based training to use the portal.
Study NCT05376358 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Adolescents and parents in the usual care arm will receive instructions to download the AWARE app. This app will only track data and will not be interactive. Otherwise they will receive care as per routine by their healthcare provider team.
Study NCT06210698 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Venipuncture
Description: venipuncture
Study NCT05075525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Laser Therapy Group
Description: High Intensity Laser Therapy (HILT) and exercises will be used.
Study NCT05075525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound and Transcutaneous Electrical Nerve Stimulation Group
Description: Transcutaneous electrical nerve stimulation(TENS), ultrasound (US) will be applied.
Study NCT05075525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound and Interferential Current Stimulation Group
Description: Ultrasound (US) ,interferential current stimulation and exercise will be used.
Study NCT05337579 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Supplemental Micro Breaks
Description: Supplemental Micro Breaks, of 30 seconds after every 15 minutes of working on a static computer workstation in addition to the two 'Conventional Rest Breaks' of 15 minutes twice a day during the work hours
Study NCT05337579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supplemental Micro Breaks
Description: Supplemental Micro Breaks, of 30 seconds after every 15 minutes of working on a static computer workstation in addition to the two 'Conventional Rest Breaks' of 15 minutes twice a day during the work hours
Study NCT05337579 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Breaks
Description: Exercise Breaks, of 10 minutes, twice a day during the work hours, in addition to the two 'Conventional Rest Breaks' of 15 minutes, twice a day during the work hours.
Study NCT05337579 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise Breaks
Description: Exercise Breaks, of 10 minutes, twice a day during the work hours, in addition to the two 'Conventional Rest Breaks' of 15 minutes, twice a day during the work hours.
Study NCT01582022 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: local application for 5 minutes
Study NCT01582022 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: local application for 5 minutes
Study NCT06108713 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Addition of juggling
Description: Participants will not change ther daily activities, and participate in juggling intervention lasted 4 weeks and consisted of 12 meetings (3 trainings per week), each lasting 45 minutes.
Study NCT02520375 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prebiotic
Study NCT02520375 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Study NCT05140512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY01005
Description: LY01005 was administered as 3 intramuscular (IM) injections, 28 days apart. As concomitant medications, Casodex® (50 mg/day) was orally administered during the whole study period.
Study NCT05140512 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ZOLADEX® 3.6 mg
Description: ZOLADEX® was administered as 3 Subcutaneous (SC) injections, 28 days apart. As concomitant medications, Casodex® (50 mg/day) was orally administered during the whole study period.
Study NCT06240000 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Radiofrequency ablation
Description: Firstly, the posterior superior iliac spine was showed in the transverse plane, and it was gradually moved proximally until gluteus maximus muscle disappears and gluteus medius arises. Medial branch of the SCN is seen between iliac crest and thoracolumbar fascia as an ovoid structure. Radiofrequency device was utilized with 22-gauge 10-cm, 5 mm RF cannulas for all procedures. Cannula was placed thorough the SCN area and Sensory fiber stimulation was started between 0.3 and 0.5 V. The patient was asked for feedback on symptoms such as numbness, paresthesia or pain. If the patient did not report any sensory symptoms within the specified sensory stimulation range, the cannula was repositioned. Motor stimulation was given up to 1.5 V and it was checked whether there was any contraction or not. If there is no contraction detected, the SCN was ablated at 42° degrees centigrade for 240 seconds.
Study NCT06462300 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A meaning-centered intervention for young women with weight and shape concerns
Description: * adapted version of the manualized meaning-centered psychotherapy for cancer patients developed by van der Spek et al. (2017)~* six weekly individual online sessions, each lasting one hour~* sessions led by a certified trainer~* four sources of meaning will be explored: personal life story, dealing with life's limitations, creating one's own life, and meaningful experiences~* homework assignments designed to deepen participants' experience and reflection on meaning in their daily lives
Study NCT03761511 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotinamide
Description: Nicotinamide 4 g (capsules) or highest tolerated dose with a minimum of 2 g/d per os once daily
Study NCT03761511 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo (capsules) once daily
Study NCT06075342 — intervention group
Intervention type: BEHAVIORAL
Intervention: exercise
Description: Exercise intervention according to the training program
Study NCT05418673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB122
Description: Administered as specified in the treatment arm.
Study NCT05418673 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BIIB122-Matching Placebo
Description: Administered as specified in the treatment arm.
Study NCT05488600 — intervention group
Intervention type: BEHAVIORAL
Intervention: Executive Function Assessment
Description: Digit Span (Forward and Backward) Test, Stroop Test, Trail Making Test A and B forms, Tower of London Test were used to evaluate executive functions.
Study NCT05947994 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intracranial stenting with Credo® stent
Description: Symptomatic ischemic stroke patients were treated with Credo® Stent